LA JOLLA, California, Sept. 16 -- The Salk Institute for Biological Studies issued the following news release:

* * *

Cancer biologists are bringing in the B cell reinforcements

*

* Highlights

* Salk scientists find B cells can promote killer T cell function in a mouse model of an aggressive breast cancer, and that the antitumor benefit of CD40 agonist treatment depends on B cells

* Study addresses the major gap in r . . .

Click here for more information about our products